Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
1.890
-0.030 (-1.56%)
At close: Oct 31, 2025, 4:00 PM EDT
1.920
+0.030 (1.59%)
After-hours: Oct 31, 2025, 4:10 PM EDT
Shattuck Labs Employees
Shattuck Labs had 44 employees as of December 31, 2024. The number of employees decreased by 31 or -41.33% compared to the previous year.
Employees
44
Change (1Y)
-31
Growth (1Y)
-41.33%
Revenue / Employee
$68,114
Profits / Employee
-$1,398,045
Market Cap
121.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44 | -31 | -41.33% |
| Dec 31, 2023 | 75 | -30 | -28.57% |
| Dec 31, 2022 | 105 | 20 | 23.53% |
| Dec 31, 2021 | 85 | 26 | 44.07% |
| Dec 31, 2020 | 59 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
STTK News
- 21 days ago - Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript - Seeking Alpha
- 4 weeks ago - Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel - GlobeNewsWire
- 2 months ago - Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors - GlobeNewsWire
- 2 months ago - Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease - GlobeNewsWire
- 2 months ago - Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million - GlobeNewsWire
- 4 months ago - Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism - GlobeNewsWire
- 6 months ago - Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire